Article

AJMC® in the Press, November 19, 2021

Author(s):

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A piece by The Business Journals cited an article published in a supplement to The American Journal of Managed Care® (AJMC®). The article, “Utilizing Oncology Biosimilars to Minimize the Economic Burden Associated With Cancer Treatment: Managed Care Considerations,” discussed pharmacists’ role in providing consistent messaging about biosimilars to both health care professionals and patients with cancer.

A story by BestLife referenced a study published in a supplement to AJMC®, titled “The Economic Impact of Peanut Allergies.” The study addressed the direct and indirect costs related to peanut allergies, which affect an estimated 1.2% of the overall US population and about 2.5% of the pediatric population.

Related Videos
Jaime Murillo, MD
Ajai Chari, MD
Nihar Desai, MD, MPH
Leigh Maria Ramos-Platt, MD
Barry Byrne, MD
Giulio Cossu, MD
Dr Xin Hu
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center
Molly Dean, MSW, Siftwell
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo